Reflect Scientific Inc Revenue Growth Rates (RSCF), Current and Historic Growth - CSIMarket
CSIMarket
 


Reflect Scientific Inc  (RSCF)
 

RSCF's Revenue Growth by Quarter and Year

Reflect Scientific Inc's Revenue results by quarter and year




RSCF Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September 0.51
2nd Quarter June 0.59
1st Quarter March 0.43
FY 1.53

RSCFs Annual Revenue
Reflect Scientific Inc's Revenue in the fiscal year 2023 $ 1.08 millions
Reflect Scientific Inc's Revenue in the fiscal year 2022 $ 2.04 millions
Reflect Scientific Inc's Revenue in the fiscal year 2021 $ 2.81 millions
Reflect Scientific Inc's Revenue in the fiscal year 2019 $ 1.61 millions
Reflect Scientific Inc's Revenue in the fiscal year 2018 $ 1.55 millions




RSCF Revenue third quarter 2024 Y/Y Growth Comment
Reflect Scientific Inc reported decrease in Revenue in the third quarter 2024 by -3.01% to $ 0.51 millions, from the same quarter in 2023.
The decrease in the third quarter 2024 Reflect Scientific Inc's Revenue compares unfavorably to the Company's average Revenue growth of 5.19%.

Looking into third quarter 2024 results within Laboratory Analytical Instruments industry 19 other companies have achieved higher Revenue growth. While Reflect Scientific Inc' s Revenue decline of -3.01% ranks overall at the positon no. 2750 in the third quarter 2024.




RSCF Revenue ( Y/Y Growth %) 2024
2023 2022 2021
4th Quarter December - -60.42 % -42.17 % -50.6 %
3rd Quarter September -3.01 % 112 % -65.28 % 18.03 %
2nd Quarter June 391.67 % -78.57 % -21.13 % 42 %
1st Quarter March 79.17 % -68 % 33.93 % -
FY   - -47.06 % -27.66 % -

Financial Statements
Reflect Scientific Inc's third quarter 2024 Revenue $ 0.51 millions RSCF's Income Statement
Reflect Scientific Inc's third quarter 2023 Revenue $ 0.53 millions Quarterly RSCF's Income Statement


RSCF Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
4th Quarter December - -64.15 % 92 % 15.28 %
3rd Quarter September -12.88 % 341.67 % -55.36 % 1.41 %
2nd Quarter June 37.21 % -50 % -25.33 % 26.79 %
1st Quarter March 126.32 % -50 % -9.64 % -66.67 %
FY (Year on Year)   - -47.06 % -27.66 % -




Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #20
Healthcare Sector #398
Overall #2750

Revenue Y/Y Growth Statistics
High Average Low
118.48 % 5.19 % -64.02 %
(Dec 31 2021)   (Jun 30 2023)
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #20
Healthcare Sector #398
Overall #2750
Revenue Y/Y Growth Statistics
High Average Low
118.48 % 5.19 % -64.02 %
(Dec 31 2021)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Reflect Scientific Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
322.78 % 13.75 % -59.63 %
(Sep 30 2023)  


RSCF's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2024 Reflect Scientific Inc disclosed drop in Revenue from the second quarter by -12.88% to $ 0.51 millions, from $ 0.59 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2024 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Reflect Scientific Inc's Revenue growth quarter on quarter, overall rank is 369.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #104
Overall #369
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #104
Overall #369
Revenue Q/Q Growth Statistics
High Average Low
322.78 % 13.75 % -59.63 %
(Sep 30 2023)  


RSCF's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2024 Reflect Scientific Inc disclosed drop in Revenue from the second quarter by -12.88% to $ 0.51 millions, from $ 0.59 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2024 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Reflect Scientific Inc's Revenue growth quarter on quarter, overall rank is 369.


Reflect Scientific Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 1.72 $ 1.73 $ 1.27 $ 1.08 $ 1.37
Y / Y Revenue Growth (TTM) 25.64 % 57.93 % -17.07 % -47.08 % -42.7 %
Year on Year Revenue Growth Overall Ranking # 3562 # 0 # 2898 # 1626 # 313
Seqeuential Revenue Change (TTM) -0.68 % 36.73 % 17.37 % -21.17 % 24.84 %
Seq. Revenue Growth (TTM) Overall Ranking # 3302 # 0 # 2709 # 3047 # 2149


Cumulative Revenue growth Comment
Assuming the Reflect Scientific Inc's fiscal year would have ended in Sep 30 2024, Reflect Scientific Inc would have reprted above average annual Revenue rise of 25.64% year on year, of $ 2 millions.
This marks a slow-down of the companys growth trends and from the 57.93% increase in Jun 30 2024.

In the Healthcare sector 513 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3562.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 514
Overall # 3562

Revenue TTM Y/Y Growth Statistics
High Average Low
118.48 %
5.3 %
-64.02 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 461
S&P 500 # 3302
Cumulative Revenue growth Comment
Assuming the Reflect Scientific Inc's fiscal year would have ended in Sep 30 2024, Reflect Scientific Inc would have reprted above average annual Revenue rise of 25.64% year on year, of $ 2 millions.
This marks a slow-down of the companys growth trends and from the 57.93% increase in Jun 30 2024.

In the Healthcare sector 513 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3562.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 514
Overall # 3562

Revenue TTM Y/Y Growth Statistics
High Average Low
118.48 %
5.3 %
-64.02 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 461
S&P 500 # 3302




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RSCF's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
West Pharmaceutical Services Inc -0.08%$ -0.080 millions
Nektar Therapeutics-0.08%$ -0.083 millions
Apyx Medical Corp-0.22%$ -0.219 millions
Avantor Inc -0.34%$ -0.337 millions
Avanos Medical Inc -0.35%$ -0.352 millions
Integra Lifesciences Holdings Corp-0.41%$ -0.415 millions
Nuwellis Inc -0.59%$ -0.588 millions
Alkermes Plc -0.73%$ -0.734 millions
Prestige Consumer Healthcare Inc -0.92%$ -0.922 millions
Psychemedics Corporation-1.02%$ -1.021 millions
Petros Pharmaceuticals inc -1.34%$ -1.342 millions
10x Genomics Inc -1.39%$ -1.391 millions
Abcellera Biologics Inc -1.39%$ -1.394 millions
Nephros Inc -1.41%$ -1.409 millions
Charles River Laboratories International inc -1.64%$ -1.642 millions
Inspiremd Inc -1.67%$ -1.669 millions
Cv Sciences Inc -1.69%$ -1.691 millions
Elutia Inc -1.71%$ -1.712 millions
Enhabit Inc -1.82%$ -1.820 millions
Accuray Incorporated-1.96%$ -1.956 millions
Zimvie Inc -1.98%$ -1.984 millions
Reflect Scientific Inc-2.25%$ -2.254 millions
Upstream Bio Inc -2.25%$ -2.254 millions
Maravai Lifesciences Holdings Inc -2.49%$ -2.490 millions
Biogen Inc -2.55%$ -2.549 millions
Fresenius Medical Care Ag-2.66%$ -2.658 millions
Opko Health Inc -2.78%$ -2.779 millions
Precision Optics Corporation Inc -2.87%$ -2.874 millions
Msa Safety Inc-2.98%$ -2.985 millions
Teladoc Health Inc -2.99%$ -2.988 millions


About Reflect Scientific Inc Revenue Growth Rates (RSCF), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Reflect Scientific Inc (CIK 1103090).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001548123-24-000126
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Reflect Scientific Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.